Aethlon Medical (AEMD) Shares Outstanding (Diluted Average) (2010 - 2025)

Aethlon Medical (AEMD) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $478310.0 in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 224.23% year-over-year to $478310.0; the trailing twelve-month figure through Dec 2025 stood at $478310.0 (up 224.23% YoY), and the FY2025 full-year result was $1.6 million, up 396.93% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $478310.0, up from $304960.0 in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $15.5 million in Q2 2022 and bottomed at $133944.0 in Q3 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $2.1 million (2023), against an average of $4.9 million.
• The widest annual swing landed in 2024, when Shares Outstanding (Diluted Average) tumbled 94.61%; it then surged 396.93% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $14.5 million in 2021, then plunged by 86.43% to $2.0 million in 2022, then increased by 25.49% to $2.5 million in 2023, then slumped by 94.05% to $147520.0 in 2024, then jumped by 224.23% to $478310.0 in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $478310.0 (Q4 2025), $304960.0 (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.

Peer Comparison